Institute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
J Virol. 2014 Feb;88(3):1433-46. doi: 10.1128/JVI.01815-13. Epub 2013 Oct 30.
Hepatitis C virus (HCV) predominantly infects human hepatocytes, although extrahepatic virus reservoirs are being discussed. Infection of cells is initiated via cell-free and direct cell-to-cell transmission routes. Cell type-specific determinants of HCV entry and RNA replication have been reported. Moreover, several host factors required for synthesis and secretion of lipoproteins from liver cells, in part expressed in tissue-specific fashion, have been implicated in HCV assembly. However, the minimal cell type-specific requirements for HCV assembly have remained elusive. Here we report that production of HCV trans-complemented particles (HCVTCP) from nonliver cells depends on ectopic expression of apolipoprotein E (ApoE). For efficient virus production by full-length HCV genomes, microRNA 122 (miR-122)-mediated enhancement of RNA replication is additionally required. Typical properties of cell culture-grown HCV (HCVcc) particles from ApoE-expressing nonliver cells are comparable to those of virions derived from human hepatoma cells, although specific infectivity of virions is modestly reduced. Thus, apolipoprotein B (ApoB), microsomal triglyceride transfer protein (MTTP), and apolipoprotein C1 (ApoC1), previously implicated in HCV assembly, are dispensable for production of infectious HCV. In the absence of ApoE, release of core protein from infected cells is reduced, and production of extracellular as well as intracellular infectivity is ablated. Since envelopment of capsids was not impaired, we conclude that ApoE acts after capsid envelopment but prior to secretion of infectious HCV. Remarkably, the lack of ApoE also abrogated direct HCV cell-to-cell transmission. These findings highlight ApoE as a host factor codetermining HCV tissue tropism due to its involvement in a late assembly step and viral cell-to-cell transmission.
丙型肝炎病毒 (HCV) 主要感染人类肝细胞,尽管人们正在讨论细胞外病毒库的存在。病毒感染是通过无细胞和直接细胞间传播途径开始的。已经报道了 HCV 进入和 RNA 复制的细胞类型特异性决定因素。此外,几个宿主因子对于从肝细胞中合成和分泌脂蛋白是必需的,部分以组织特异性方式表达,这些因子被牵连到 HCV 的组装中。然而,对于 HCV 组装的最小细胞类型特异性要求仍然难以捉摸。在这里,我们报告称,非肝细胞中丙型肝炎病毒转互补颗粒 (HCVTCP) 的产生依赖于载脂蛋白 E (ApoE) 的异位表达。对于全长 HCV 基因组的有效病毒产生,还需要 microRNA 122 (miR-122) 介导的 RNA 复制增强。来自表达 ApoE 的非肝细胞的 HCV 培养物生长的典型特性与源自人肝癌细胞的病毒粒子相似,尽管病毒粒子的特异性感染性适度降低。因此,先前被牵连到 HCV 组装中的载脂蛋白 B (ApoB)、微粒体甘油三酯转移蛋白 (MTTP) 和载脂蛋白 C1 (ApoC1) 在产生感染性 HCV 时是可有可无的。在没有 ApoE 的情况下,感染细胞中核心蛋白的释放减少,并且细胞外和细胞内感染性的产生被消除。由于衣壳的包膜不受影响,我们得出结论,ApoE 在衣壳包膜后但在分泌感染性 HCV 之前起作用。值得注意的是,缺乏 ApoE 也消除了直接的 HCV 细胞间传播。这些发现强调了 ApoE 作为一种宿主因子,由于其参与晚期组装步骤和病毒细胞间传播,因此决定了 HCV 的组织嗜性。